![From QSR to QMSR: Meeting FDA’s New Requirements From QSR to QMSR: Meeting FDA’s New Requirements](https://www.fdanews.com/ext/resources/Book-Covers-NEW/From-QSR-to-QMSR-500.png?height=200&t=1714569011&width=200)
Home » ASTRAZENECA SEEKS TO REASSURE INVESTORS
ASTRAZENECA SEEKS TO REASSURE INVESTORS
June 8, 2006
AstraZeneca PLC sought to reassure investors Thursday that its existing products can underpin earnings growth while the drugmaker
replenishes its thin pipeline of future drugs.
Business
Week
KEYWORDS Daily International Pharma Alert
Upcoming Events
-
21Oct